Apixaban no better than aspirin for preventing some strokes

A multicenter, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to new research.

Related Keywords

Canada ,United States ,American ,Hooman Kamel ,Mitchell Elkind ,Presbyterian Columbia University Irving Medical Center ,Columbia University Vagelos College Of Physicians ,Department Of Neurology ,Presbyterian Weill Cornell Medical Center ,American Heart Association ,Research Institute At Weill Cornell Medicine ,Weill Cornell Medicine ,Columbia University Vagelos College ,Albert Moon Professor ,Translational Neuroscience Unit ,Feil Family Brain ,Mind Research Institute ,Weill Cornell Medical ,Columbia University Irving Medical ,American Heart ,Atrial Cardiopathy ,